Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: The CINDERELLA trial

Podobne zapisy

• Randomised phase I/II study to evaluate <it>c</it>arbon <it>i</it>o<it>n </it>ra<it>d</it>ioth<it>e</it>rapy ve<it>r</it>sus fractionat<it>e</it>d stereotactic radiotherapy in patients with recurrent or progressive g<it>l</it>iom<it>a</it>s: The CINDERELLA trial
  od: Haselmann Renate, i wsp.
  Wydane: (2010-10-01)
• Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: The MARCIE Trial
  od: Combs, Stephanie E, i wsp.
  Wydane: (2010)
• Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: The PROMETHEUS-01 trial
  od: Combs, Stephanie E, i wsp.
  Wydane: (2011)
• Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial
  od: Combs, Stephanie E, i wsp.
  Wydane: (2010)
• Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects
  od: Harrabi, Semi B, i wsp.
  Wydane: (2014)